AmacaThera Inc.: Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies
AmacaThera, a leading clinical-stage biotechnology company revolutionizing long-acting therapies, announces the appointment ...
Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies
AmacaThera, a leading clinical-stage biotechnology company revolutionizing long-acting therapies, announces the appointment ...
News248h
Revolutionising male birth control: Stellenbosch graduate paves the way with reversible tech
Stellenbosch University graduate Dr Kyla Raoult develops a revolutionary hydrogel offering a reversible, non-hormonal ...
New paper batteries biodegrade in six weeks, offers safer energy storage
Flint's paper batteries biodegrade within six weeks, offering a sustainable alternative to traditional energy storage.
Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices
TSXV:IOT) Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices ...
ConsumerQueen on MSN17h
Ulta Deals | Love Your Skin Event!
Looking for Ulta Deals and coupons? You've come to the right place, we'll update this post each week with the latest offers ...
PharmiWeb22h
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...
Zomedica Corp.: Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...